Molecular Mechanisms of Cancer Invasion and Metastasis
Metastasis is one of the major obstacles to the treatment of any cancer. Surgical management of cancer with no lymph node or organ metastasis is generally uncomplicated, but the treatment of metastatic disease remains challenging. Acquisition of increased motility by cancer cells seems to be a requirement for cancer invasion and metastasis, and during the process of cell movement, the actin cytoskeleton is dynamically remodeled by the functions of various classes of actin-binding proteins.
Identification of actinin-4 as a biomarker of cancer invasion and an indicator of prognosis for cancer patients
Actinin-4 was identified in our laboratory as a novel actin-binding protein associated with increased cell motility and cancer invasion (1). Breast cancer(PDF:27KB) patients with cytoplasmic and/or cell membrane localization of actinin-4 were found to have a poorer outcome than breast cancer patients with nuclear localization. Actinin-4 expression has also been found to be significantly correlated with the outcome of colorectal(PDF:27KB) (2), ovarian (3), and pancreatic cancer patients (4). In addition, gene amplification of ACTN4 was observed in ovarian (5) and pancreatic cancers (4). We have found that an increase in DNA copy number of ACTN4 seems to predict poor prognosis in patients with high-grade ovarian carcinomas(PDF:23KB) (5).
Actinin-4 increases cell motility and promotes lymph node metastasis
of colorectal cancer
Overexpression of actinin-4 promoted the formation of cellular
protrusions(PDF:27KB) and cell motility (2).
When actinin-4-expressing colorectal cancer cells were injected into the
mesocecum of severe combined immunodeficient (SCID) mice, they metastasized
to regional mesenteric lymph nodes(PDF:27KB) in a manner resembling
the behavior of clinical cancers (2).
E-cadherin regulates the association between β-catenin and actinin-4
The E-cadherin/catenin system acts as an invasion suppressor of various
epithelial malignancies. However, loss of cell adhesion is insufficient
to explain its full invasion suppressive activity, and involvement of some
β-catenin-binding protein has been speculated. We searched for the
molecule linking E-cadherin/catenin to cell motility by a proteomic approach
and were surprised to discover that it was actinin-4. Immunofluorescence
histochemistry(PDF:27KB) of colorectal cancer specimens showed that
the -catenin and actinin-4 proteins were colocalized in colorectal cancer
cells infiltrating the stroma (6).
References
1. Honda
et al., J Cell Biol 140:1383-1393, 1998.
2. Honda
et al., Gastroenterology 128:51-62, 2005
3. Yamamoto
et al., Mod Pathol 20:1278-1285, 2007.
4. Kikuchi
et al., Clin Cancer Res 14:5348-5356, 2008
5. Yamamoto
et al., Mod Pathol 22:499-507, 2009.
6. Hayashida
et al., Cancer Res 65:8836-8845, 2005.
7. Honda
et al., Oncogene 23:5257-5262, 2004.
8. Hara
et al., Mol Cell Proteomics 6:479-491, 2007.
9. Honda
et al., Seikagaku 79:643-54, 2007.